SI wins Queen's Award for Ent

RNS Number : 5028K
Surgical Innovations Group PLC
21 April 2010



Press Release

21 April 2010


Surgical Innovations Group plc


("SI" or "the Group")


 Surgical Innovations wins Queen's Award for Enterprise



Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, is pleased to announce that it has been awarded a Queen's Award for Enterprise, the UK's most prestigious award for outstanding innovation and business performance.


The award, under the Innovation category, acknowledges the technical and clinical excellence achieved with SI's pioneering YelloPort+Plus® , a port access system which acts as a channel into the body, allowing surgeons to carry out delicate keyhole procedures.    


The Resposable® YelloPort+Plus® device combines both reusable and disposable elements to offer surgeons and hospitals around the world a cost effective but high quality solution for laparoscopic surgery. The durable, lightweight and ergonomically designed device was developed following close collaboration with surgeons in order to meet their needs and provide the highest levels of patient care. 


Commenting on the award Graham Bowland, Managing Director of Surgical Innovations, said: "We are delighted to win such a prestigious award for our contribution to the healthcare industry.  SI was one of the first companies to develop flexible but rigid laparoscopic devices and has since gained a worldwide reputation for developing and manufacturing innovative devices.  Last year our new laparoscopic training centre was officially opened by Lord Davies of Abersoch, Minister for Trade Investment and Small Business.  The Queen's Award is a tribute to the dedication of our employees from design through to production and acknowledges Yorkshire's cutting edge healthcare technologies industry.


"During the last year, we have seen increasing revenues and have invested heavily in the Group's R&D facilities.  Our sales agreement with Premier, the US-based Group Purchasing Organisation, will help drive uptake of our products in this highly lucrative market and will contribute further to the Group's international growth prospects.  With the number of laparoscopic procedures and the need for innovative tools increasing globally, we look forward to the positive impact we expect that this award will have on the business."


The awards are given each year by Her Majesty Queen Elizabeth II on her birthday, 21 April, on the advice of the Prime Minister, assisted by an Advisory Committee comprising representatives of Government, industry, commerce and the trade unions. 


All Surgical Innovations' products are designed and manufactured in-house.  Last year the Group moved to a new 32,000sq ft headquarters in Leeds, more than tripling the size of its facilities.  The Group has also doubled the number of employees and invested in all areas of the business throughout 2009 to meet the challenges of future growth.


- Ends -


For further information:

Surgical Innovations Group plc

Doug Liversidge, Non-Executive Chairman

Tel: +44 (0) 113 230 7597

Graham Bowland, Managing Director

Tel: +44 (0) 113 230 7597


Westhouse Securities Limited

Tim Feather / Matthew Johnson

Tel: +44 (0) 113 246 2611


Media enquiries:

Abchurch Communications

Sarah Hollins / Simone Elviss / Quincy Allan

Tel: +44 (0) 20 7398 7728



Notes to Editors:


About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets.  The Group has two divisions Surgical Innovations Limited and Haemocell Limited.


The Group employs over 80 people and has its manufacturing facility based in Leeds, covering 32,000 square feet, which enables the in-house design and manufacture of its own products to the highest quality standards. Surgical Innovations, through an established network of 40 distribution partners, sells in all of the major medical markets including North America, Europe, South Africa, the Middle East, South-East Asia and Australia.


Surgical Innovations Limited, which is the main division of the Group, is focused on developing medical instruments for the laparoscopic surgery market, minimally invasive surgery of the abdomen. The Group has pioneered the resposable™ concept, which combines both single use and reusable components which ensures an ongoing revenue stream and delivers the optimum procedure performance to cost ratio. The Groups products include:


YelloPort plus

a resposable™ laparoscopic port access system that combines both single-use and reusable components

Logi™ Range

laparoscopic instrument system using resposable™ technology to deliver the cost effectiveness of a reusable instrument with the optimum performance of a disposable.

Quick Range

single-use instruments, with an ergonomic handle to ensure accurate control of the instrument. The range includes scissors, graspers and dissectors


In addition to its own branded instruments, the Group also designs and manufactures devices on a private label basis for large medical device companies including Teleflex Medical, Gyrus, Olympus and Cardinal Health


Haemocell Limited specialises in equipment for Autologous Blood Transfusion, which is the collection and re-infusion of a patient's own blood either during or after surgery, eliminating the widely-documented risks of infection from donated blood


For more information, see


This information is provided by RNS
The company news service from the London Stock Exchange
UK 100

Latest directors dealings